- Home
- ISPO vs ELEV Comparison
ISPO vs ELEV Comparison
Compare ISPO & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- ELEV
- Stock Information
- Founded
- ISPO 2010
- ELEV 2019
- Country
- ISPO United States
- ELEV United States
- Employees
- ISPO N/A
- ELEV N/A
- Industry
- ISPO Blank Checks
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- ELEV Health Care
- Exchange
- ISPO Nasdaq
- ELEV Nasdaq
- Market Cap
- ISPO 39.0M
- ELEV 37.6M
- IPO Year
- ISPO N/A
- ELEV 2021
- Fundamental
- Price
- ISPO $6.99
- ELEV $0.71
- Analyst Decision
- ISPO Buy
- ELEV Buy
- Analyst Count
- ISPO 2
- ELEV 6
- Target Price
- ISPO $10.50
- ELEV $7.20
- AVG Volume (30 Days)
- ISPO 71.9K
- ELEV 4.2M
- Earning Date
- ISPO 03-04-2025
- ELEV 03-05-2025
- Dividend Yield
- ISPO N/A
- ELEV N/A
- EPS Growth
- ISPO N/A
- ELEV N/A
- EPS
- ISPO N/A
- ELEV N/A
- Revenue
- ISPO $287,451,000.00
- ELEV N/A
- Revenue This Year
- ISPO N/A
- ELEV N/A
- Revenue Next Year
- ISPO N/A
- ELEV N/A
- P/E Ratio
- ISPO N/A
- ELEV N/A
- Revenue Growth
- ISPO N/A
- ELEV N/A
- 52 Week Low
- ISPO $3.11
- ELEV $0.50
- 52 Week High
- ISPO $9.31
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- ISPO 87.48
- ELEV 53.28
- Support Level
- ISPO $3.26
- ELEV $0.65
- Resistance Level
- ISPO $3.75
- ELEV $0.98
- Average True Range (ATR)
- ISPO 0.49
- ELEV 0.11
- MACD
- ISPO 0.31
- ELEV 0.00
- Stochastic Oscillator
- ISPO 95.40
- ELEV 36.63
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.